Cart
sales@molnova.com
Dazoxiben
CAS No. 74226-22-5
Dazoxiben( UK-37248 )
Catalog No. M21159 CAS No. 74226-22-5
Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 2MG | 43 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 250 | In Stock |
|
| 50MG | 361 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1070 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDazoxiben
-
NoteResearch use only, not for human use.
-
Brief DescriptionDazoxiben is a potent inhibitor of thromboxane (TX) synthase.
-
DescriptionDazoxiben is a potent inhibitor of thromboxane (TX) synthase.
-
In Vitro——
-
In Vivo——
-
SynonymsUK-37248
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorThromboxane (TX) synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74226-22-5
-
Formula Weight268.7
-
Molecular FormulaC12H13ClN2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (232.60 mM; Need ultrasonic)
-
SMILESCl.O=C(O)c1ccc(OCCn2ccnc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Patrignani P Filabozzi P Catella F et al. Differential effects of dazoxiben a selective thromboxane-synthase inhibitor on platelet and renal prostaglandin-endoperoxide metabolism.[J]. journal of pharmacology & experimental therapeutics 1984 228(2):472-477.
molnova catalog
related products
-
Bupivacaine hydrochl...
Bupivacaine hydrochloride binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells.
-
Gestonorone Capronat...
Gestonorone Capronate? is a progesterone used in benign prostatic hyperplasia and endometrial cancer studies.
-
ONO-8713
ONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist used to study diseases of the biblical system and metabolism-related diseases.
